Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 10
Submit an article Journal homepage
91
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients with Poor-prognosis Acute Myeloid Leukemia

G.J. Roboz Weill Medical College of Cornell University and The New York Presbyterian Hospital, New York, NY, USA
,
M.A. Knovich Wake Forest University School of Medicine, Winston-Salem, NC, USA
,
R.L. Bayer Weill Medical College of Cornell University and The New York Presbyterian Hospital, New York, NY, USA
,
M.W. Schuster Weill Medical College of Cornell University and The New York Presbyterian Hospital, New York, NY, USA
,
K. Seiter New York Medical College, Valhalla, NY, USA
,
B.L. Powell Wake Forest University School of Medicine, Winston-Salem, NC, USA
,
R.D. Woodruff Wake Forest University School of Medicine, Winston-Salem, NC, USA
,
R.T. Silver Weill Medical College of Cornell University and The New York Presbyterian Hospital, New York, NY, USA
,
A.E. Frankel Wake Forest University School of Medicine, Winston-Salem, NC, USA
&
E.J. Feldman Weill Medical College of Cornell University and The New York Presbyterian Hospital, New York, NY, USA
 show all
Pages 1951-1955 | Published online: 03 Aug 2009

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Marie-Luise Hütter & Richard F Schlenk. (2011) Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia. Expert Opinion on Biological Therapy 11:10, pages 1369-1380.
Read now
Hideo Uchida, Koiti Inokuchi, Reiko Watanabe, Michihide Tokuhira & Masahiro Kizaki. (2008) New therapeutic approaches to acute myeloid leukemia. Expert Opinion on Drug Discovery 3:6, pages 689-706.
Read now
Roberto Stasi. (2008) Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia. Expert Opinion on Biological Therapy 8:4, pages 527-540.
Read now
Gail J Roboz. (2007) Treatment of acute myeloid leukemia in older patients. Expert Review of Anticancer Therapy 7:3, pages 285-295.
Read now
Wolfgang R Sperr, Stefan Florian, Alexander W Hauswirth & Peter Valent. (2005) CD33 as a target of therapy in acute myeloid leukemia: current status and future perspectives. Leukemia & Lymphoma 46:8, pages 1115-1120.
Read now
AP Grigg, J Reynolds, A McQuillan, SK Juneja, J Di Iulio, C Hui, C Smith, R Kimber, KF Bradstock & on behalf of the Australasian Leukaemia and Lymphoma Group. (2005) Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine. Leukemia & Lymphoma 46:3, pages 367-375.
Read now
Pier Paolo Piccaluga, Giovanni Martinelli, Michela Rondoni, Michele Malagola, Stavroula Gaitani, Alessandro Isidori, Alessandro Bonini, Luigi Gugliotta, Mario Luppi, Monica Morselli, Giovanni Sparaventi, Giuseppe Visani & Michele Baccarani. (2004) Gemtuzumab Ozogamicin for Relapsed and Refractory Acute Myeloid Leukemia and Myeloid Sarcomas. Leukemia & Lymphoma 45:9, pages 1791-1795.
Read now

Articles from other publishers (22)

Monalisha Sengupta, Arijit Guha, Rudranil Bhowmik, Imran Kazmi, Salman Bakr I. Hosawi, Fahad Al-Abbasi & Mohammed Kaleem. 2023. How Synthetic Drugs Work. How Synthetic Drugs Work 477 502 .
Kelly J. Norsworthy, Chia-Wen Ko, Jee Eun Lee, Jiang Liu, Christy S. John, Donna Przepiorka, Ann T. Farrell & Richard Pazdur. (2018) FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia. The Oncologist 23:9, pages 1103-1108.
Crossref
Phillip M. Garfin & Eric J. Feldman. (2016) Antibody-Based Treatment of Acute Myeloid Leukemia. Current Hematologic Malignancy Reports 11:6, pages 545-552.
Crossref
George S. Laszlo, Elihu H. Estey & Roland B. Walter. (2014) The past and future of CD33 as therapeutic target in acute myeloid leukemia. Blood Reviews 28:4, pages 143-153.
Crossref
Atiqur Rahman. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 747 762 .
Luis Villela & Javier Bolaños-Meade. (2011) Acute Myeloid Leukaemia. Drugs 71:12, pages 1537-1550.
Crossref
Aaron S. Kesselheim. (2021) Off-Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech. American Journal of Law & Medicine 37:2-3, pages 225-257.
Crossref
Wassim McHayleh, Kenneth Foon, Robert Redner, Rajesh Sehgal, Anastasios Raptis, Mounzer Agha, The Minh Luong, James J. Schlesselman & Michael Boyiadzis. (2010) Gemtuzumab ozogamicin as first‐line treatment in patients aged 70 years or older with acute myeloid leukemia. Cancer 116:12, pages 3001-3005.
Crossref
Enrique Espinosa & César Gómez Raposo. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics 3 35 .
Andrea Kuendgen & Ulrich Germing. (2009) Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly. Cancer Treatment Reviews 35:2, pages 97-120.
Crossref
Deborah Mulford. (2008) Antibody Therapy for Acute Myeloid Leukemia. Seminars in Hematology 45:2, pages 104-109.
Crossref
Sergio Amadori & Roberto Stasi. (2008) Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia. Current Opinion in Hematology 15:2, pages 95-100.
Crossref
Roberto Stasi, Maria Laura Evangelista, Francesco Buccisano, Adriano Venditti & Sergio Amadori. (2008) Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia. Cancer Treatment Reviews 34:1, pages 49-60.
Crossref
István Molnár & Bayard L. Powell. (2007) What role does gemtuzumab ozogamicin have in the treatment of acute myelogenous leukemia?. Current Hematologic Malignancy Reports 2:2, pages 104-110.
Crossref
Maria-Theresa Krauth, Alexandra Böhm, Hermine Agis, Karoline Sonneck, Puchit Samorapoompichit, Stefan Florian, Karl Sotlar & Peter Valent. (2007) Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils. Experimental Hematology 35:1, pages 108-116.
Crossref
Sergio Amadori & Roberto Stasi. (2006) Monoclonal antibodies and immunoconjugates in acute myeloid leukemia. Best Practice & Research Clinical Haematology 19:4, pages 715-736.
Crossref
Caroline Fenton & Caroline M Perry. (2005) Gemtuzumab Ozogamicin. Drugs 65:16, pages 2405-2427.
Crossref
Michael Rosenblum. 2004. Treatment of Leukemia and Lymphoma. Treatment of Leukemia and Lymphoma 209 228 .
Atiqur Rahman. 2004. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 523 537 .
Enrique Espinosa, Pilar Zamora, Jaime Feliu & Manuel González Barón. (2003) Classification of anticancer drugs—a new system based on therapeutic targets. Cancer Treatment Reviews 29:6, pages 515-523.
Crossref
. (2003) Current Awareness: Pharmacoepidemiology and Drug Safety. Pharmacoepidemiology and Drug Safety 12:3, pages 253-268.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:1, pages 43-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.